Radical Bio is the therapeutics division of Immuto Scientific, built to advance a proprietary pipeline and forge discovery partnerships across oncology, immunology, and other disease areas.
Radical Bio is discovering and developing first-in-class biologics by targeting structural changes—rather than sequence or expression—in cell surface proteins.
Our proprietary Rover Target Discovery and RADAR Structural Epitope Discovery platforms combine high-resolution proteomics, live-cell structural analysis, and AI-enabled computation to map Surface Protein Conformers (SPCs) – disease-specific structural states of cell surface proteins that are invisible to conventional genomics and proteomics. These conformational insights unlock first-in-class, epitope-specific therapeutics with the potential for exceptional precision, safety, and translational success.
We’re illuminating what conventional approaches can’t see – unlocking a new frontier in targeted therapeutics.
Company Details
- Employees
- 1
- Address
- 1 Broadway, Cambridge,massachusetts 02142,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://radical.bio
- HQ
- Cambridge, Massachusetts
- Competitors
- Koneksa, Immuto Scientific, Pranava Group.
Radical Bio Questions
Radical Bio's website is https://radical.bio
Radical Bio's LinkedIn profile is https://www.linkedin.com/company/radical-bio
Radical Bio has
1 employees.
View email and phone details for 1
employees at Radical Bio.
Radical Bio's industry is
Biotechnology Research
Radical Bio's categories are Biotechnology Research
